Piper Sandler Maintains Overweight on Gossamer Bio, Maintains $15 Price Target
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Yasmeen Rahimi maintains an Overweight rating on Gossamer Bio (GOSS) with a $15 price target.
March 27, 2024 | 4:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler reaffirms an Overweight rating and a $15 price target on Gossamer Bio.
The reaffirmation of an Overweight rating and a $15 price target by a reputable analyst like Yasmeen Rahimi from Piper Sandler could instill confidence among investors and potentially lead to a positive short-term price movement for Gossamer Bio.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100